Gubra A/S - Asset Resilience Ratio

Latest as of December 2025: 79.61%

Gubra A/S (GUBRA) has an Asset Resilience Ratio of 79.61% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See financial agility of Gubra A/S to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

Dkr1.05 Billion
≈ $164.40 Million USD Cash + Short-term Investments

Total Assets

Dkr1.32 Billion
≈ $206.50 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2023–2025)

This chart shows how Gubra A/S's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Gubra A/S to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Gubra A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Gubra A/S market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Dkr0.00 0%
Short-term Investments Dkr1.05 Billion 79.61%
Total Liquid Assets Dkr1.05 Billion 79.61%

Asset Resilience Insights

  • Very High Liquidity: Gubra A/S maintains exceptional liquid asset reserves at 79.61% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Gubra A/S Industry Peers by Asset Resilience Ratio

Compare Gubra A/S's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
argenx NV ADR
NASDAQ:ARGX
Biotechnology 10.93%
Royalty Pharma Plc
NASDAQ:RPRX
Biotechnology 0.11%
Tubize-Fin
BR:TUB
Biotechnology 0.05%
SillaJen Inc
KQ:215600
Biotechnology 50.41%
Verona Pharma plc
F:I9SA
Biotechnology 0.00%
Abivax SA
PA:ABVX
Biotechnology 2.34%
ABL Bio Inc
KQ:298380
Biotechnology 0.69%
Xiamen Amoytop Biotech Co Ltd
SHG:688278
Biotechnology 4.69%

Annual Asset Resilience Ratio for Gubra A/S (2023–2025)

The table below shows the annual Asset Resilience Ratio data for Gubra A/S.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 79.61% Dkr1.05 Billion
≈ $164.40 Million
Dkr1.32 Billion
≈ $206.50 Million
+32.62pp
2024-12-31 47.00% Dkr287.84 Million
≈ $45.03 Million
Dkr612.48 Million
≈ $95.83 Million
-17.61pp
2023-12-31 64.61% Dkr403.99 Million
≈ $63.21 Million
Dkr625.28 Million
≈ $97.83 Million
--
pp = percentage points

About Gubra A/S

CO:GUBRA Denmark Biotechnology
Market Cap
$848.91 Million
Dkr5.43 Billion DKK
Market Cap Rank
#9769 Global
#46 in Denmark
Share Price
Dkr332.20
Change (1 day)
+0.12%
52-Week Range
Dkr317.40 - Dkr534.00
All Time High
Dkr728.00
About

Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for th… Read more